Mutations in genes encoding the ATP-regulated potassium (K(ATP)) channels of the pancreatic beta-cell (SUR1 and Kir6.2) are the major known cause of persistent hyperinsulinemic hypoglycemia of infancy (PHHI). We collected all cases of PHHI diagnosed in Finland between 1983 and 1997 (n = 24). The overall incidence was 1:40,400, but in one area of Central Finland it was as high as 1:3,200. Haplotype analysis using polymorphic markers spanning the SUR1/Kir6.2 gene cluster confirmed linkage to the 11p region. Sequence analysis revealed a novel point mutation in exon 4 of SUR1, predicting a valine to aspartic acid change at amino acid 187 (V187D). Of the total cases, 15 affected individuals harbored this mutation in heterozygous or homozygous form, and all of these had severe hyperinsulinemia that responded poorly to medical treatment and required subtotal pancreatectomy. No K(ATP) channel activity was observed in beta-cells isolated from a homozygous patient or after coexpression of recombinant Kir6.2 and SUR1 carrying the V187D mutation. Thus, the mutation produces a nonfunctional channel and, thereby, continuous insulin secretion. This unique SUR1 mutation explains the majority of PHHI cases in Finland and is strongly associated with a severe form of the disease. These findings provide diagnostic and prognostic utility for suspected PHHI patients.
Skip Nav Destination
Article navigation
Abstract|
February 01 1999
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
T Otonkoski;
T Otonkoski
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
C Ammälä;
C Ammälä
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
H Huopio;
H Huopio
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
G J Cote;
G J Cote
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
J Chapman;
J Chapman
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
K Cosgrove;
K Cosgrove
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
R Ashfield;
R Ashfield
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
E Huang;
E Huang
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
J Komulainen;
J Komulainen
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
F M Ashcroft;
F M Ashcroft
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
M J Dunne;
M J Dunne
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
J Kere;
J Kere
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
P M Thomas
P M Thomas
Transplantation Laboratory, Haartman Institute,and University of Helsinki, Finland. [email protected]
Search for other works by this author on:
Citation
T Otonkoski, C Ammälä, H Huopio, G J Cote, J Chapman, K Cosgrove, R Ashfield, E Huang, J Komulainen, F M Ashcroft, M J Dunne, J Kere, P M Thomas; A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.. Diabetes 1 February 1999; 48 (2): 408–415. https://doi.org/10.2337/diabetes.48.2.408
Download citation file: